Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The State Food and Drug Administration (SFDA) in China has awarded reinspection approval of Good Manufacturing Practice (GMP) certificate to Huifeng Bio-Pharmaceutical Technology on 7 September 2010.
Subscribe to our email newsletter
All pharmaceutical companies in China are required by SFDA to gain GMP certificate, which is valid for five years, for the production of pharmaceuticals.
Huifeng Bio-Pharmaceutical is a developer and producer of botanical extracts and other raw materials for pharmaceuticals and food additives.
Huifeng Bio-Pharmaceutical CEO Jing’an Wang said that the approval of GMP certificate has a significant impact on the company’s future success and further proves the superior quality standards of their products.
“This certification allows us to move forward to expand not only our domestic market but also our oversea markets, such as in U.S., India, European countries, Japan and South America as GMP is required by their government,” Wang said.